Literature DB >> 28005151

Activated protein C binds directly to Tie2: possible beneficial effects on endothelial barrier function.

Nikita Minhas1, Meilang Xue1, Christopher J Jackson2.   

Abstract

Activated protein C (APC) is a natural anticoagulant with strong anti-inflammatory, anti-apoptotic, and barrier stabilizing properties. These cytoprotective properties of APC are thought to be exerted through its pathway involving the binding of APC to endothelial protein C receptor and cleavage of protease-activated receptors. In this study, we found that APC enhanced endothelial barrier integrity via a novel pathway, by binding directly to and activating Tie2, a transmembrane endothelial tyrosine kinase receptor. Binding assays demonstrated that APC competed with the only known ligands of Tie2, the angiopoietins (Angs). APC bound directly to Tie2 (Kd ~3 nM), with markedly stronger binding affinity than Ang2. After binding, APC rapidly activated Tie2 to enhance endothelial barrier function as shown by Evan's blue dye transfer across confluent cell monolayers and in vivo studies. Blocking Tie2 restricted endothelial barrier integrity. This study highlights a novel mechanism by which APC binds directly to Tie2 to enhance endothelial barrier integrity, which helps to explain APC's protective effects in vascular leakage-related pathologies.

Entities:  

Keywords:  Biacore; Endothelial barrier integrity; Immunoprecipitation; Protease-activated receptor; Protein C; RCR252; SDS-PAGE; Sepsis; Solid-phase binding assay

Mesh:

Substances:

Year:  2016        PMID: 28005151     DOI: 10.1007/s00018-016-2440-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  70 in total

1.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove.

Authors:  Jacinto López-Sagaseta; Cristina Puy; Ibai Tamayo; Mikel Allende; Jorge Cerveró; Susana E Velasco; Charles T Esmon; Ramón Montes; José Hermida
Journal:  Blood       Date:  2011-12-13       Impact factor: 22.113

3.  Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis.

Authors:  D E Joyce; L Gelbert; A Ciaccia; B DeHoff; B W Grinnell
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

4.  Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage.

Authors:  Fiorentina Roviezzo; Stelios Tsigkos; Anastasia Kotanidou; Mariarosaria Bucci; Vincenzo Brancaleone; Giuseppe Cirino; Andreas Papapetropoulos
Journal:  J Pharmacol Exp Ther       Date:  2005-05-03       Impact factor: 4.030

5.  Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency.

Authors:  Angelina J Lay; Deborah Donahue; Meng-Ju Tsai; Francis J Castellino
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

6.  Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period.

Authors:  Gavin Thurston; Quan Wang; Fabienne Baffert; John Rudge; Nicholas Papadopoulos; Danielle Jean-Guillaume; Stanley Wiegand; George D Yancopoulos; Donald M McDonald
Journal:  Development       Date:  2005-06-15       Impact factor: 6.868

7.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Authors:  Clemens Feistritzer; Matthias Riewald
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

8.  Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke.

Authors:  M Shibata; S R Kumar; A Amar; J A Fernandez; F Hofman; J H Griffin; B V Zlokovic
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

9.  'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.

Authors:  Nicole C Kaneider; Andrew J Leger; Anika Agarwal; Nga Nguyen; George Perides; Claudia Derian; Lidija Covic; Athan Kuliopulos
Journal:  Nat Immunol       Date:  2007-10-28       Impact factor: 25.606

10.  Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.

Authors:  K Murakami; K Okajima; M Uchiba; M Johno; T Nakagaki; H Okabe; K Takatsuki
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

View more
  13 in total

1.  Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation-A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients.

Authors:  Michael Hultström; Karin Fromell; Anders Larsson; Barbro Persson; Bo Nilsson; Susan E Quaggin; Christer Betsholtz; Robert Frithiof; Miklos Lipcsey; Marie Jeansson
Journal:  Biomedicines       Date:  2022-06-06

2.  Sex-dependent effects of genetic upregulation of activated protein C on delayed effects of acute radiation exposure in the mouse heart, small intestine, and skin.

Authors:  Vijayalakshmi Sridharan; Kristin A Johnson; Reid D Landes; Maohua Cao; Preeti Singh; Gail Wagoner; Abdallah Hayar; Emily D Sprick; Kayla A Eveld; Anusha Bhattacharyya; Kimberly J Krager; Nukhet Aykin-Burns; Hartmut Weiler; Jose A Fernández; John H Griffin; Marjan Boerma
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

3.  Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.

Authors:  Christopher Daly; Xiaozhong Qian; Carla Castanaro; Elizabeth Pasnikowski; Xiabo Jiang; Benjamin R Thomson; Susan E Quaggin; Nicholas Papadopoulos; Yang Wei; John S Rudge; Gavin Thurston; George D Yancopoulos; Samuel Davis
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

4.  Neuroprotective Effect of Activated Protein C on Blood-Brain Barrier Injury During Focal Cerebral Ischemia/Reperfusion.

Authors:  Jinqiao Wang; Gaofeng Rao; Yifan Ma; Jingjing Zhang; Jingjing Shen; Chaohong Shi
Journal:  Dose Response       Date:  2020-05-04       Impact factor: 2.658

5.  β-arrestin-2 in PAR-1-biased signaling has a crucial role in endothelial function via PDGF-β in stroke.

Authors:  Hideaki Kanki; Tsutomu Sasaki; Shigenobu Matsumura; Satoru Yokawa; Toshiro Yukami; Munehisa Shimamura; Manabu Sakaguchi; Tadahide Furuno; Takahiro Suzuki; Hideki Mochizuki
Journal:  Cell Death Dis       Date:  2019-02-04       Impact factor: 8.469

6.  Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction.

Authors:  Tami Livnat; Yehonatan Weinberger; José A Fernández; Alaa Bashir; Gil Ben-David; Dahlia Palevski; Sarina Levy-Mendelovich; Gili Kenet; Ivan Budnik; Yael Nisgav; John H Griffin; Dov Weinberger
Journal:  Biomolecules       Date:  2021-02-26

Review 7.  Coagulation Dysfunction in Acute Respiratory Distress Syndrome and Its Potential Impact in Inflammatory Subphenotypes.

Authors:  Samantha A Livingstone; Karin S Wildi; Heidi J Dalton; Asad Usman; Katrina K Ki; Margaret R Passmore; Gianluigi Li Bassi; Jacky Y Suen; John F Fraser
Journal:  Front Med (Lausanne)       Date:  2021-08-20

Review 8.  Activated protein C, protease activated receptor 1, and neuroprotection.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

9.  PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.

Authors:  Ranjeet K Sinha; Yaoming Wang; Zhen Zhao; Xiao Xu; Laurent Burnier; Naveen Gupta; José A Fernández; Greg Martin; Sergey Kupriyanov; Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2018-01-17       Impact factor: 25.476

Review 10.  Endothelial Activation: The Ang/Tie Axis in Sepsis.

Authors:  Aleksandra Leligdowicz; Melissa Richard-Greenblatt; Julie Wright; Valerie M Crowley; Kevin C Kain
Journal:  Front Immunol       Date:  2018-04-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.